Table 2 Baseline characteristics of the patients
Variable | Group A (Active PEMF) | Group B (Placebo) |
|---|---|---|
Number | 51 | 51 |
Age – year* | 35 (18 - 70) | 34 (18 - 77) |
Days between fracture and start of treatment* | 4.25 (0 - 5) | 3.69 (0 - 5) |
Male (n, %) | 40 (78) | 38 (75) |
Fracture in dominant hand (n,%) | 28 (55) | 29 (57) |
Anatomical snuff box tenderness (n, %) | 46 (90) | 49 (96) |
Pain with longitudinal compression (n, %) | 39 (77) | 45 (88) |
Fracture type [17] (n, %) | ||
- Tubercle (A1) | 9 (18) | 9 (18) |
- Transverse waist, undisplaced (A2) | 19 (37) | 20 (39) |
- Oblique (B1) | 15 (29) | 18 (35) |
- Transverse waist with distraction (B2) | 8 (16) | 4 (8) |
Comorbidities (n, %) | ||
- None | 34 (67) | 38 (75) |
- Osteoporosis | 0 (0) | 0 (0) |
- Corticosteroids | 0 (0) | 1 (2) |
- Multiple | 1 (2) | 1 (2) |
Smoking (n, %) | 16 (31) | 11 (22) |